Loading…
Reported covered position: Health Policy Advisor - Senate Committee on Health, Education, Labor and Pensions; Staff member - Senate Committee on Health, Education, Labor and Pensions
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
FDA regulation of CBD FDA Rare Disease PPRV program/reauthorization Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Most Favored Nation drug pricing Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act HR 946: Orphan Cures Act
FDA regulation of CBD FDA Rare Disease PPRV program/reauthorization Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Most Favored Nation drug pricing Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act HR 946: Orphan Cures Act Legislation Related to the Repeal or Reform of Orphan Cures Section 232 Tariffs
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2026 · third_quarter · Q3
FDA regulation of CBD FDA Rare Disease PPRV program/reauthorization Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Most Favored Nation drug pricing Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act HR 946: Orphan Cures Act Legislation Related to the Repeal or Reform of Orphan Cures Section 232 Tariffs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
FDA regulation of CBD FDA Rare Disease PPRV program/reauthorization Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Most Favored Nation drug pricing Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act HR 946: Orphan Cures Act Legislation Related to the Repeal or Reform of Orphan Cures Section 232 Tariffs
FDA regulation of CBD FDA Rare Disease PPRV program/reauthorization Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Most Favored Nation drug pricing Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act HR 946: Orphan Cures Act
S.2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act HR 8467 - Farm, Food, and National Security Act of 2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2025 Control status of Epidiolex Changes to Inflation Reduction Act Drug safety, prescription drug abuse, value of prescription drugs Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
S.2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act HR 8467 - Farm, Food, and National Security Act of 2024 Hemp definition Changes to Inflation Reduction Act Drug safety, prescription drug abuse, value of prescription drugs Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
S.2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act Drug safety, prescription drug abuse, value of prescription drugs Changes to the Inflation Reduction Act Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
S. 2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act HR 8467 - Farm, Food, and National Security Act of 2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2025 Control status of Epidiolex Changes to Inflation Reduction Act Drug safety, prescription drug abuse, value of prescription drugs Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
S.2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act HR 8467 - Farm, Food, and National Security Act of 2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2025 Control status of Epidiolex Changes to Inflation Reduction Act Drug safety, prescription drug abuse, value of prescription drugs Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
Farm, Food, and National Security Act of 2024
Client: JAZZ PHARMACEUTICALS, INC. · Firm: JAZZ PHARMACEUTICALS, INC.
S. 2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act HR 8467 - Farm, Food, and National Security Act of 2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2025 Control status of Epidiolex Changes to Inflation Reduction Act Drug safety, prescription drug abuse, value of prescription drugs Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
Farm, Food, and National Security Act of 2024
Client: JAZZ PHARMACEUTICALS, INC. · Firm: JAZZ PHARMACEUTICALS, INC.
S.2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act HR 8467 - Farm, Food, and National Security Act of 2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2025 Control status of Epidiolex Changes to Inflation Reduction Act Drug safety, prescription drug abuse, value of prescription drugs Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
Farm, Food, and National Security Act of 2024
Client: JAZZ PHARMACEUTICALS, INC. · Firm: JAZZ PHARMACEUTICALS, INC.
S.2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act HR 8467 - Farm, Food, and National Security Act of 2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2025 Control status of Epidiolex Changes to Inflation Reduction Act Drug safety, prescription drug abuse, value of prescription drugs Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
Farm, Food, and National Security Act of 2024
Client: JAZZ PHARMACEUTICALS, INC. · Firm: JAZZ PHARMACEUTICALS, INC.
S.2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act HR 8467 - Farm, Food, and National Security Act of 2024 Hemp definition Changes to Inflation Reduction Act Drug safety, prescription drug abuse, value of prescription drugs Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
S.2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act Drug safety, prescription drug abuse, value of prescription drugs Changes to the Inflation Reduction Act Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
S.2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act HR 8467 - Farm, Food, and National Security Act of 2024 Hemp definition Changes to Inflation Reduction Act Drug safety, prescription drug abuse, value of prescription drugs Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
S. 2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act HR 8467 - Farm, Food, and National Security Act of 2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2025 Control status of Epidiolex Changes to Inflation Reduction Act Drug safety, prescription drug abuse, value of prescription drugs Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
S.2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act HR 8467 - Farm, Food, and National Security Act of 2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2025 Control status of Epidiolex Changes to Inflation Reduction Act Drug safety, prescription drug abuse, value of prescription drugs Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
S.2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act HR 8467 - Farm, Food, and National Security Act of 2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2025 Control status of Epidiolex Changes to Inflation Reduction Act Drug safety, prescription drug abuse, value of prescription drugs Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
S.2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act HR 8467 - Farm, Food, and National Security Act of 2024 Hemp definition Changes to Inflation Reduction Act Drug safety, prescription drug abuse, value of prescription drugs Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
S.2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act Drug safety, prescription drug abuse, value of prescription drugs Changes to the Inflation Reduction Act Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
S. 2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act HR 8467 - Farm, Food, and National Security Act of 2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2025 Control status of Epidiolex Changes to Inflation Reduction Act Drug safety, prescription drug abuse, value of prescription drugs Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
S.2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act HR 8467 - Farm, Food, and National Security Act of 2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2025 Control status of Epidiolex Changes to Inflation Reduction Act Drug safety, prescription drug abuse, value of prescription drugs Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
S.2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act HR 8467 - Farm, Food, and National Security Act of 2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2025 Control status of Epidiolex Changes to Inflation Reduction Act Drug safety, prescription drug abuse, value of prescription drugs Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
SAFE Banking Act of 2021
Client: JAZZ PHARMACEUTICALS, INC. · Firm: JAZZ PHARMACEUTICALS, INC.
H.R. 1996 - SAFE Banking Act of 2021 Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations, and FDA regulation and enforcement FDA regulation of cannabis derived products
SAFE Banking Act of 2021
Client: JAZZ PHARMACEUTICALS, INC. · Firm: JAZZ PHARMACEUTICALS, INC.
H.R.1996 - SAFE Banking Act of 2021 Cannabis Administration & Opportunity Act Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations, and FDA regulation and enforcement. FDA regulation of cannabis-derived products
SAFE Banking Act of 2021
Client: JAZZ PHARMACEUTICALS, INC. · Firm: JAZZ PHARMACEUTICALS, INC.
H.R.1996 - SAFE Banking Act of 2021 Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations, and FDA regulation and enforcement
Elijah E. Cummings Lower Drug Costs Now Act
Client: JAZZ PHARMACEUTICALS, INC. · Firm: JAZZ PHARMACEUTICALS, INC.
HR 3 - Drug pricing Reform
Elijah E. Cummings Lower Drug Costs Now Act
Client: JAZZ PHARMACEUTICALS, INC. · Firm: JAZZ PHARMACEUTICALS, INC.
HR 3 - Drug pricing
2026 · second_quarter · Q2
FDA regulation of CBD FDA Rare Disease PPRV program/reauthorization Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Most Favored Nation drug pricing Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act HR 946: Orphan Cures Act Legislation Related to the Repeal or Reform of Orphan Cures Section 232 Tariffs
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2026 · first_quarter · Q1
FDA regulation of CBD FDA Rare Disease PPRV program/reauthorization Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Most Favored Nation drug pricing Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act HR 946: Orphan Cures Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2025 · fourth_quarter · Q4
FDA regulation of CBD FDA Rare Disease PPRV program/reauthorization Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Most Favored Nation drug pricing Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act HR 946: Orphan Cures Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2024 · fourth_quarter · 4A
S. 2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act HR 8467 - Farm, Food, and National Security Act of 2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2025 Control status of Epidiolex Changes to Inflation Reduction Act Drug safety, prescription drug abuse, value of prescription drugs Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2024 · third_quarter · 3A
S.2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act HR 8467 - Farm, Food, and National Security Act of 2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2025 Control status of Epidiolex Changes to Inflation Reduction Act Drug safety, prescription drug abuse, value of prescription drugs Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2024 · third_quarter · Q3
S.2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act HR 8467 - Farm, Food, and National Security Act of 2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2025 Control status of Epidiolex Changes to Inflation Reduction Act Drug safety, prescription drug abuse, value of prescription drugs Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2024 · second_quarter · Q2
S.2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act HR 8467 - Farm, Food, and National Security Act of 2024 Hemp definition Changes to Inflation Reduction Act Drug safety, prescription drug abuse, value of prescription drugs Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2024 · first_quarter · 1A
S.2860 - SAFER Banking Act HR 5539/ S. 3131 - Orphan Cures Act Drug safety, prescription drug abuse, value of prescription drugs Changes to the Inflation Reduction Act Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2024 · first_quarter · Q1
Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2023 · fourth_quarter · 4A
Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies SAFE Banking Act 2023
Filing targets: HOUSE OF REPRESENTATIVES, Natl Credit Union Administration (NCUA), SENATE
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2023 · fourth_quarter · Q4
Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies SAFE Banking Act 2023
Filing targets: HOUSE OF REPRESENTATIVES, Natl Credit Union Administration (NCUA), SENATE
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2023 · third_quarter · Q3
Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies SAFE Banking Act 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2023 · second_quarter · Q2
Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations and FDA regulation/enforcement Drug safety, prescription drug abuse and drug pricing SAFE Banking Act 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2023 · first_quarter · RA
Pharmaceutical manufacturing and healthcare.
Pharmaceutical manufacturing and healthcare.
Pharmaceutical manufacturing and healthcare.
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2023 · first_quarter · Q1
Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations and FDA regulation and enforcement Drug safety, prescription drug abuse and drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2023 · first_quarter · Q1
Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations and FDA regulation and enforcement Drug safety, prescription drug abuse and drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2022 · third_quarter · Q3
H.R. 1996 - SAFE Banking Act of 2021 Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations, and FDA regulation and enforcement FDA regulation of cannabis derived products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2022 · second_quarter · Q2
H.R.1996 - SAFE Banking Act of 2021 Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations, and FDA regulation and enforcement
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2022 · first_quarter · 1A
H.R.1996 - SAFE Banking Act of 2021 Cannabis Administration & Opportunity Act Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations, and FDA regulation and enforcement. FDA regulation of cannabis-derived products
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2022 · first_quarter · RA
Pharmaceutical manufacturing and healthcare
Pharmaceutical manufacturing and healthcare
Pharmaceutical manufacturing and healthcare
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2021 · fourth_quarter · Q4
HR 3 - Drug pricing Reform
Filing targets: SENATE
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2021 · third_quarter · Q3
HR 3 - Drug pricing
Filing targets: SENATE
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2021 · second_quarter · Q2
Drug pricing
Filing targets: SENATE
JAZZ PHARMACEUTICALS, INC. via JAZZ PHARMACEUTICALS, INC.
2021 · second_quarter · RR
Pharmaceutical manufacturing and healthcare
Pharmaceutical manufacturing and healthcare
Pharmaceutical manufacturing and healthcare
Pharmaceutical manufacturing and healthcare.
Pharmaceutical manufacturing and healthcare.
Pharmaceutical manufacturing and healthcare
Pharmaceutical manufacturing and healthcare
Pharmaceutical manufacturing and healthcare
Pharmaceutical manufacturing and healthcare